Cargando…

Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease

Obesity and associated comorbidities, including non-alcoholic fatty liver disease (NAFLD), are a major concern to public well-being worldwide due to their high prevalence among the population, and its tendency on the rise point to as important threats in the future. Therapeutic approaches for obesit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Porras, David, Nistal, Esther, Martínez-Flórez, Susana, González-Gallego, Javier, García-Mediavilla, María Victoria, Sánchez-Campos, Sonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305464/ https://www.ncbi.nlm.nih.gov/pubmed/30618824 http://dx.doi.org/10.3389/fphys.2018.01813

Ejemplares similares

Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease
por: Carbajo-Pescador, Sara, et al.
Publicado: (2019)

Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children
por: Quiroga, Rocío, et al.
Publicado: (2020)

The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation
por: Juárez-Fernández, María, et al.
Publicado: (2021)

Aging, Gut Microbiota and Metabolic Diseases: Management through Physical Exercise and Nutritional Interventions
por: Juárez-Fernández, María, et al.
Publicado: (2020)

Long-Term Effects of Bariatric Surgery on Gut Microbiota Composition and Faecal Metabolome Related to Obesity Remission
por: Juárez-Fernández, María, et al.
Publicado: (2021)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Contrasting Effects of Fasting on Liver-Adipose Axis in Alcohol-Associated and Non-alcoholic Fatty Liver
por: Rasineni, Karuna, et al.
Publicado: (2021)

Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
por: Shi, Dongmei, et al.
Publicado: (2019)

Pathogenesis of Alcohol-Associated Fatty Liver: Lessons From Transgenic Mice
por: Ferdouse, Afroza, et al.
Publicado: (2022)

Antisense Oligonucleotide Technologies to Combat Obesity and Fatty Liver Disease
por: Keating, Michael F., et al.
Publicado: (2022)

Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease
por: Wang, Jincheng, et al.
Publicado: (2022)

The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
por: Hartmann, Phillipp, et al.
Publicado: (2012)

Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease
por: Watt, Joanne, et al.
Publicado: (2022)

Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression
por: Juárez‐Fernández, María, et al.
Publicado: (2023)

Regulatory Non-coding RNAs Network in Non-alcoholic Fatty Liver Disease
por: Sulaiman, Siti Aishah, et al.
Publicado: (2019)

Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
por: Brandt, Annette, et al.
Publicado: (2019)

A new role for inflammasomes: sensing the disturbances in non-alcoholic fatty liver disease
por: Desai, Poorvi, et al.
Publicado: (2013)

The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis
por: Mazzoccoli, Gianluigi, et al.
Publicado: (2018)

The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development
por: Cunningham, Rory P., et al.
Publicado: (2020)

Molecular pathways in non-alcoholic fatty liver disease
por: Berlanga, Alba, et al.
Publicado: (2014)

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease
por: Li, Shaobo, et al.
Publicado: (2021)

Editorial: Metabolism in nonalcoholic fatty liver disease
por: Najjar, Sonia Michael, et al.
Publicado: (2023)

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2014)

Dysregulated Neurovascular Control Underlies Declining Microvascular Functionality in People With Non-alcoholic Fatty Liver Disease (NAFLD) at Risk of Liver Fibrosis
por: Clough, Geraldine F., et al.
Publicado: (2020)

Hepcidin in morbidly obese women with non-alcoholic fatty liver disease
por: Auguet, Teresa, et al.
Publicado: (2017)

Factors Determining Colorectal Cancer: The Role of the Intestinal Microbiota
por: Nistal, Esther, et al.
Publicado: (2015)

Lack of Adrenomedullin Aggravates Acute TNBS-Induced Colitis Symptoms in Mice, Especially in Females
por: Martínez-Herrero, Sonia, et al.
Publicado: (2017)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Modulatory effect of camel milk on intestinal microbiota of mice with non-alcoholic fatty liver disease
por: Hao, Shiqi, et al.
Publicado: (2022)

PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
por: Aragonès, Gemma, et al.
Publicado: (2016)

Green Plant Pigment, Chlorophyllin, Ameliorates Non-alcoholic Fatty Liver Diseases (NAFLDs) Through Modulating Gut Microbiome in Mice
por: Yang, You, et al.
Publicado: (2021)

Polyene Phosphatidylcholine Ameliorates High Fat Diet-Induced Non-alcoholic Fatty Liver Disease via Remodeling Metabolism and Inflammation
por: Lu, Yang, et al.
Publicado: (2022)

Qingchang Wenzhong Decoction Prevents the Occurrence of Intestinal Tumors by Regulating Intestinal Microbiota and Gasdermin E
por: Ren, Lingli, et al.
Publicado: (2022)

The AMPK pathway in fatty liver disease
por: Fang, Chunqiu, et al.
Publicado: (2022)

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
por: Sharma, Satya Priya, et al.
Publicado: (2021)

Acute Alcohol-Induced Liver Injury
por: Massey, Veronica L., et al.
Publicado: (2012)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Commensal Homeostasis of Gut Microbiota-Host for the Impact of Obesity
por: Zhang, Pengyi, et al.
Publicado: (2018)

Protective Properties of FOXO1 Inhibition in a Murine Model of Non-alcoholic Fatty Liver Disease Are Associated With Attenuation of ER Stress and Necroptosis
por: Ding, Hao-ran, et al.
Publicado: (2020)

The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease
por: Ayob, Nurainina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8rrlffvsihs6b972hum2lfsucq